首页> Clinical colorectal cancer> Escalated Segmental and Modified Radiation Lobectomy Dosing for Yttrium-90 Radioembolization of Liver-Dominant Metastatic Colorectal Cancer: 10-year Outcomes.

Escalated Segmental and Modified Radiation Lobectomy Dosing for Yttrium-90 Radioembolization of Liver-Dominant Metastatic Colorectal Cancer: 10-year Outcomes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Andrew C,Gordon

第一单位： Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, IL.

作者： Andrew C,Gordon ^[1] ; Saad Abu,Zahra ^[1] ; Muhamad,Serhal ^[1] ; Sheetal M,Kircher ^[2] ; Aparna,Kalyan ^[2] ; Kent,Sato ^[1] ; Ahsun,Riaz ^[1] ; Elias,Hohlastos ^[1] ; Riad,Salem ^[3] ; Robert J,Lewandowski ^[4]

作者单位： Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, IL. ^[1] Department of Medicine, Division of Hematology and Oncology, Northwestern University, Chicago, IL. ^[2] Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, IL; Department of Medicine, Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL; Department of Surgery, Division of Transplant Surgery, Northwestern University, Chicago, IL. ^[3] Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, IL; Department of Medicine, Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL; Department of Surgery, Division of Transplant Surgery, Northwestern University, Chicago, IL. Electronic address: r-lewandowski@northwestern.edu. ^[4]

关键词 Metastatic colorectal cancer Radioembolization Survival Yttrium-90